Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESThe pharmaceutical industry has rarely seen the level of volatility, uncertainty, complexity and ambiguity (VUCA) that caused by the COVID-19 pandemic. The result has been an evolution of forecasting tools and techniques, as conventional forecasting methods struggled to account for such dramatic events.
Forecasting is about predicting future events based on past results. When a marketplace is stable, these methods are the cornerstone of the planning process. But the sweeping VUCA created by the pandemic and other market events made it impossible for pharma forecasters to predict future outcomes due to a lack of historical data to inform them.
At an IQVIA event in Sep 2020, about six months into the pandemic, almost half1 of industry professionals surveyed said COVID has had at least a major impact on their forecasting teams, and five percent called it “a massive headache” and said they are struggling to cope with the deluge of new data and requests.
Instead of lamenting the shortcomings of an outdated process, the pandemic should be seen as a wakeup call for forecasters that they need to identify ways to deliver faster, more accurate results - especially in times of rapid change.
Because while the pandemic is an extreme example of VUCA, disruptive events happen all the time in this market. Entrance of new competitors, release of trial results, a changing political environment around reimbursement, and the release of game changing therapeutic innovations make slow-to-update forecasts increasingly irrelevant and introduce new kinds of risk to the forecasting process.
As Donald Rumsfeld famously said: “There are known knowns — there are things we know we know. We also know there are known unknowns — that is to say, we know there are some things we do not know. But there are also unknown unknowns, the ones we don’t know we don’t know.” These ‘unknown unknowns’ — like the unexpected COVID-19 pandemic — can sometimes carry great risk, and forecasters have to figure out how to manage them when they appear.
To do this, we’re proposing a set of changes to the forecast process that are focused around driving down the time it takes to re-forecast when a change occurs.
Imagine being able to make significant changes to a commercial forecast and communicate those changes to senior leadership in three minutes or less. That is the type of responsiveness executives would hope for from a forecast in times of volatility. And it’s possible — when forecasters make two significant changes to their process.
The combination of external data and advanced technology transforms the forecast from a static document that can be rendered rapidly obsolete in volatile times, to a powerful predictive tool that adapts with the market.
For example, these new platforms enable another trend that is vital to forecasting in a crisis – cross-department collaboration. To generate the most accurate and up-to-date information, forecasters may need to coordinate cross-functionally with supply chain, marketing, finance and regulatory professionals, who will determine which data sets are required to understand how the crisis will affect the product and what they can do to mitigate risks and maximize results.
With conventional forecasting methods, gathering this data takes weeks of back and forth. With advanced forecasting platforms, stakeholder groups can link their own data directly to the platform and update it as needed, eliminating the need for forecast teams to track it down and streamlining the process significantly.
The COVID-19 crisis exposed critical weaknesses in commercial forecasting processes and has challenged forecasters to be more adaptive. In times of rapid change, forecasters need to align the cadence of their analysis and reporting to the level of disruption in the marketplace and the urgency of action required by the company. To do that, they can’t waste time on the mechanics of updating the forecast - they need to be able to get straight to the insights.
When forecasters transform their processes to recognize and react to changing trends, they become the ‘first responders,’ able to inform leaders about how unexpected events impact future plans.
Contact us at ForecastHorizon@iqvia.com for information about the Forecast Horizon platform and better managing VUCA!
1 September 2020 Client-facing, IQVIA sponsored webinar “Commercial Forecasting in a Time of Rapid Change”